期刊文献+

聚-(羟丙基、丙基)-天冬酰胺材料体外酶解及植入小鼠体内的观察 被引量:1

Poly-(hydroxypropyl,propyl)-asparamide:Enzymatic hydrolysis in vitro and in vivo
下载PDF
导出
摘要 目的 :观察 4种不同摩尔比的聚 -(羟丙基、丙基 ) -天冬酰胺材料在体外酶解和植入小鼠体内后的变化。方法 :用木瓜蛋白酶和胰酶对材料作了体外酶解试验 ,用凝胶色谱法对降解物碎片作了测定 ;用光镜、扫描电镜、透射电镜等对材料在埋植部位、肝、肾组织内的降解碎片进行观察 ;对材料植入小鼠体内后的生化指标 (血红蛋白、白细胞、谷丙转氨酶、肌酐作了测定。结果 :聚 -(羟丙基、丙基 ) -天冬酰胺材料在体外能被逐步酶解。在植入小鼠体内的 5周内 ,在埋植部位、肝、肾组织内能观察到材料的碎片。结论 :聚 -(羟丙基、丙基 ) -天冬酰胺材料能在体内、外逐步降解 ,植入小鼠体内后对动物的血象、肝、肾功能无明显的影响 。 Objective: To explore the biochemical process of poly (hydroxypropyl,propyl) asparamide .Methods: Enzymatic hydrolysis in vitro was carried out by trypsin and papain.The polymer was implanted in mice.The degradation fragments were analyzed by gel permeation chromatography.The histopathological changes of implantation site,liver and kidney were observed by microscopy and electron microscopy.The hemogram of mice were also measured.Results: The experiment showed that the polymer was hydrolysed by the enzymic action gradually.The hemogram and serum biochemical parameters showed no changes after the polymer was implanted in experimental animals.Conclusion: The polymer shows no side effect on the experiment animal,and can be degraded gradually in vitro and in vivo.
出处 《浙江大学学报(医学版)》 CAS CSCD 2001年第4期145-149,共5页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金资助项目 (395 70 2 19) 浙江省分析测试基金 (970 5 9)
关键词 天冬酰胺 生物相容性材料 聚-(羟丙基、丙基)-天冬酰胺 体外酶解 体内降解 小鼠 Asparagine Biocompatible materials Poly (hydroxypropyl,propyl) asparamide Enzymatic hydrolysis Implantation Mice
  • 相关文献

参考文献8

二级参考文献27

共引文献22

同被引文献19

  • 1赵彦生,闫丰文,弭勇.聚天冬氨酸衍生物药物控释体系的研究进展[J].现代化工,2005,25(12):24-27. 被引量:5
  • 2王希,支晓兴.聚(乳酸-天冬氨酸)生物降解材料的合成及性能研究[J].广东化工,2005,32(12):22-24. 被引量:3
  • 3郝杰,郑启新,郭晓东.三嵌段高分子骨组织工程支架材料的体内生物学性能评价[J].中国临床康复,2006,10(21):49-51. 被引量:3
  • 4牵玉宝.纳米生物医药材料[M].北京:化学工业出版社,2004.
  • 5GiammonaG, CarlisiB, PalazzoA, et at Carrier potymers.Synthesis of a new multiaspartic hydrazide [J]. Boll China Farm,1989,128 (2):62-64
  • 6Giammona G, Cathsi B, Cavallaro G. A new water-soluble synthetic polymer, α,β-polyasparthydrazide, as potential plasma expander and drug carrier[J]. Control Rel 1994;29(1-2):63-72
  • 7Giammona G, Pitarresi G, Tornarehio V. Crosslinked α,β- polyasparthydrazide hydrogels: effect of crosslinking degree and loading method on cytarabine release rate [J]. Journal of controlled release, 1996,41(3): 195-203
  • 8Giammona G, Tomarehio V, Pitarresi G. Glycidyl methacrylate derivatization of α,β-poly (N-hydroxyethyl)- DL-aspartamide and α,β-polyasparthydrazide [J]. Polymer,1997,38(13):3315-3323
  • 9Mendiehi R, Giaeometti S A, CavaUaro G, et al. Molecular characterization of α,β-poly (N-2-hydroxyethyl)-DL-aspartamide derivatives as potential self-assembling copolymers forming polymeric micelles[J]. PolymerS003, 44(17):4871"4879
  • 10CavaUaro G, Maniscalco L, Lieeiardi M. Tamoxifen-loaded polymeric micelles:preparation, physico-chemical characterization and in vitro evaluation studies [J]. Macromolecular Bioscience, 2004,4(11):1028-1038

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部